Compare RGEN & AUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | AUR |
|---|---|---|
| Founded | 1981 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 11.4B |
| IPO Year | 1995 | 2021 |
| Metric | RGEN | AUR |
|---|---|---|
| Price | $177.23 | $5.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 13 |
| Target Price | ★ $189.70 | $12.05 |
| AVG Volume (30 Days) | 880.1K | ★ 28.8M |
| Earning Date | 10-27-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 286.96 | 4.35 |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $141,236,000.00 | $3,000,000.00 |
| Revenue This Year | $12.04 | $399.72 |
| Revenue Next Year | $17.80 | $1,200.30 |
| P/E Ratio | $805.46 | ★ N/A |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $3.60 |
| 52 Week High | $198.87 | $8.57 |
| Indicator | RGEN | AUR |
|---|---|---|
| Relative Strength Index (RSI) | 63.35 | 35.44 |
| Support Level | $159.22 | $3.94 |
| Resistance Level | N/A | $5.54 |
| Average True Range (ATR) | 6.58 | 0.35 |
| MACD | 0.98 | -0.11 |
| Stochastic Oscillator | 75.63 | 15.29 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.